ATOM Consortium Welcomes 3 DOE National Laboratories to Accelerate Drug Discovery

March 29, 2021

SAN FRANCISCO, March 29, 2021 — The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium today announced the U.S. Department of Energy’s Argonne, Brookhaven and Oak Ridge national laboratories are joining the consortium to further develop ATOM’s artificial intelligence (AI)-driven drug discovery platform.

The public-private ATOM consortium aims to transform drug discovery from a slow, sequential and high-risk process into a rapid, integrated and patient-centric model. Founded in 2017, ATOM is developing a pre-competitive, pre-clinical drug design platform that integrates diverse data types such as physicochemical properties, in vitro assay results and anonymized human clinical data, with AI, high-performance computing (HPC) and advanced experimental technologies. The goal is to shorten the drug discovery timeline from five years to less than one year.

“Bringing the experience and expertise from three additional DOE national laboratories to ATOM’s current partners, including the Frederick National Laboratory for Cancer Research (FNL), sponsored by the National Cancer Institute, reinforces ATOM as a valuable national resource to create powerful new capabilities for the cancer research community, building collaborations and driving advances in translational research to develop treatments more quickly,” said Eric Stahlberg, director of the Biomedical Informatics and Data Science group at FNL and co-lead of the ATOM consortium. “As the nation’s only national laboratory focused exclusively on biomedical research, including cancer, AIDS and emerging health threats, FNL has significant resources to apply to the challenges in finding new and effective treatments, and we are thrilled to add these new members to help ATOM achieve its lofty and potentially transformational goals.”

“It’s exciting to welcome three new national laboratories into the expanded ATOM consortium,” added Jim Brase, deputy associate director for computing at Lawrence Livermore National Laboratory and ATOM co-lead. “Their combined world-class expertise and experience in computing, simulation and machine learning will accelerate our progress toward molecular design of new therapeutics for the public good.”

Argonne National Laboratory (ANL) is a leader in high-performance computing and computer sciences, including data science, applied mathematics and computational science. As a member of the consortium, the Argonne Leadership Computing Facility will be leveraged to perform advanced simulations in life sciences, including molecular biology, microbiology, protein chemistry, bioinformatics, computational biology, environmental sciences and other scientific fields. Through this collaboration, Argonne will extend its deep expertise in creating groundbreaking machine learning analytics in biological and life sciences, and gain access to unique and complementary data in predictive biology and medicinal chemistry. Additionally, with its Aurora exascale computing system planned for 2022, Argonne will contribute unmatched computation resources to this collaboration.

“We are excited to officially join the ATOM consortium, having collaborated closely with  members on scientific research efforts since its formation,” said Rick Stevens, Argonne associate laboratory director for Computing, Environment and Life Sciences. “At Argonne we are actively developing and applying computational and machine learning approaches to a broad range of challenges in life sciences, including drug screening for COVID-19 and cancer. We look forward continuing these efforts as part of the ATOM consortium.”

Within ATOM, Brookhaven National Laboratory (BNL) will share its experience in creating scalable HPC frameworks that support optimal experimental design (OED) active-learning workflows for advanced simulations. These frameworks are designed to engage machine learning that can work with the complex, nonlinear and uncertain aspects that tend to characterize cancer drug therapy research. BNL’s contributions will include model-data integration, developing a reinforcement learning/active learning-guided OED workflow that works on the existing drug candidate dataset and designing a software framework to support scalable, adaptive algorithms used in the drug design and simulation pipeline.

“At Brookhaven, we are excited to apply our team’s work developing and using optimization algorithms directly to ATOM’s diverse computational data-driven modeling efforts,” said Francis J. “Frank” Alexander, deputy director of the Computational Science Initiative. “Often, mathematical models and systems of interest to ATOM cancer therapy problems are uncertain and under-characterized due to their extremely complex nature. At Brookhaven, our artificial intelligence, machine learning and applied mathematics work aims to unravel complexities to design computational and laboratory experiments that achieve discovery goals in the most efficient manner. We believe these efforts will have significant applications in ATOM that can greatly benefit and enhance the program’s impact. We look forward to contributing as part of the collaboration.”

Oak Ridge National Laboratory (ORNL) is the largest Department of Energy science and energy laboratory with expertise in accelerating scientific discovery through modeling and simulation on powerful supercomputers, data-intensive science and biological systems research. ORNL will apply its unique capabilities to examine the complex and dynamic interactions between candidate molecules and the human body. This approach, focused on quantitative systems pharmacology, predicts the window between an effective low dose of a drug and a higher dose that would be likely to elicit adverse effects. To better predict these therapeutic parameters, scientists are combining AI with systems models that represent proteins, organs and cellular processes. These data about relevant biological processes will integrate into the ATOM workflow to increase the chances of success when molecules go to clinical trials. ORNL is also building the nation’s first exascale-class supercomputer, Frontier, which will allow researchers to solve increasingly complex biological problems when it comes online in late 2021.

“Tightly coupling these quantitative systems pharmacology models with the larger AI workflow is what sets ATOM apart from other AI-driven drug discovery methods,” said Marti Head, who played a pivotal role in the formation of ATOM during her time at GlaxoSmithKline and now serves as director of the ORNL-University of Tennessee Joint Institute for Biological Sciences. “By integrating high-performance computing, simulation, and big data with chemistry and biology at scale, we can think about drug discovery in one coherent, networked piece and get drugs to patients faster with a greater probability of success. Thinking about the challenges we’ve all been struggling with since the start of the COVID-19 pandemic in March of 2020 is a perfect example of why having these drug discovery tools that can operate holistically and help us move faster is so important for the world.”

About ATOM

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission of transforming drug discovery by accelerating the development of more effective therapies for patients. ATOM’s goal is to transform drug discovery from a slow, sequential, and high-failure process into a rapid, integrated, and patient-centric model. The consortium is integrating high performance computing, diverse biological data, and emerging biotechnologies to create a new pre-competitive platform for drug discovery. Visit www.atomscience.org.

About ANL

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

About BNL

Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nation’s future. Primarily supported by DOE’s Office of Science, Brookhaven Lab is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 37 R&D 100 Awards, and more than 70 years of pioneering research. Brookhaven is managed for the Office of Science by Brookhaven Science Associates, a partnership between Stony Brook University and Battelle. For more information, visit https://energy.gov/science.

About ORNL

Oak Ridge National Laboratory delivers scientific discoveries and technical breakthroughs needed to realize solutions in energy and national security and provide economic benefit to the nation. ORNL is managed by UT-Battelle for the DOE Office of Science, the single largest supporter of basic research in the physical sciences in the United States. DOE’s Office of Science is working to address some of the most pressing challenges of our time. For more information, please visit https://energy.gov/science.


Source: BNL

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industry updates delivered to you every week!

AI Saves the Planet this Earth Day

April 22, 2024

Earth Day was originally conceived as a day of reflection. Our planet’s life-sustaining properties are unlike any other celestial body that we’ve observed, and this day of contemplation is meant to provide all of us Read more…

Intel Announces Hala Point – World’s Largest Neuromorphic System for Sustainable AI

April 22, 2024

As we find ourselves on the brink of a technological revolution, the need for efficient and sustainable computing solutions has never been more critical.  A computer system that can mimic the way humans process and s Read more…

Empowering High-Performance Computing for Artificial Intelligence

April 19, 2024

Artificial intelligence (AI) presents some of the most challenging demands in information technology, especially concerning computing power and data movement. As a result of these challenges, high-performance computing Read more…

Kathy Yelick on Post-Exascale Challenges

April 18, 2024

With the exascale era underway, the HPC community is already turning its attention to zettascale computing, the next of the 1,000-fold performance leaps that have occurred about once a decade. With this in mind, the ISC Read more…

2024 Winter Classic: Texas Two Step

April 18, 2024

Texas Tech University. Their middle name is ‘tech’, so it’s no surprise that they’ve been fielding not one, but two teams in the last three Winter Classic cluster competitions. Their teams, dubbed Matador and Red Read more…

2024 Winter Classic: The Return of Team Fayetteville

April 18, 2024

Hailing from Fayetteville, NC, Fayetteville State University stayed under the radar in their first Winter Classic competition in 2022. Solid students for sure, but not a lot of HPC experience. All good. They didn’t Read more…

AI Saves the Planet this Earth Day

April 22, 2024

Earth Day was originally conceived as a day of reflection. Our planet’s life-sustaining properties are unlike any other celestial body that we’ve observed, Read more…

Kathy Yelick on Post-Exascale Challenges

April 18, 2024

With the exascale era underway, the HPC community is already turning its attention to zettascale computing, the next of the 1,000-fold performance leaps that ha Read more…

Software Specialist Horizon Quantum to Build First-of-a-Kind Hardware Testbed

April 18, 2024

Horizon Quantum Computing, a Singapore-based quantum software start-up, announced today it would build its own testbed of quantum computers, starting with use o Read more…

MLCommons Launches New AI Safety Benchmark Initiative

April 16, 2024

MLCommons, organizer of the popular MLPerf benchmarking exercises (training and inference), is starting a new effort to benchmark AI Safety, one of the most pre Read more…

Exciting Updates From Stanford HAI’s Seventh Annual AI Index Report

April 15, 2024

As the AI revolution marches on, it is vital to continually reassess how this technology is reshaping our world. To that end, researchers at Stanford’s Instit Read more…

Intel’s Vision Advantage: Chips Are Available Off-the-Shelf

April 11, 2024

The chip market is facing a crisis: chip development is now concentrated in the hands of the few. A confluence of events this week reminded us how few chips Read more…

The VC View: Quantonation’s Deep Dive into Funding Quantum Start-ups

April 11, 2024

Yesterday Quantonation — which promotes itself as a one-of-a-kind venture capital (VC) company specializing in quantum science and deep physics  — announce Read more…

Nvidia’s GTC Is the New Intel IDF

April 9, 2024

After many years, Nvidia's GPU Technology Conference (GTC) was back in person and has become the conference for those who care about semiconductors and AI. I Read more…

Nvidia H100: Are 550,000 GPUs Enough for This Year?

August 17, 2023

The GPU Squeeze continues to place a premium on Nvidia H100 GPUs. In a recent Financial Times article, Nvidia reports that it expects to ship 550,000 of its lat Read more…

Synopsys Eats Ansys: Does HPC Get Indigestion?

February 8, 2024

Recently, it was announced that Synopsys is buying HPC tool developer Ansys. Started in Pittsburgh, Pa., in 1970 as Swanson Analysis Systems, Inc. (SASI) by John Swanson (and eventually renamed), Ansys serves the CAE (Computer Aided Engineering)/multiphysics engineering simulation market. Read more…

Intel’s Server and PC Chip Development Will Blur After 2025

January 15, 2024

Intel's dealing with much more than chip rivals breathing down its neck; it is simultaneously integrating a bevy of new technologies such as chiplets, artificia Read more…

Choosing the Right GPU for LLM Inference and Training

December 11, 2023

Accelerating the training and inference processes of deep learning models is crucial for unleashing their true potential and NVIDIA GPUs have emerged as a game- Read more…

Baidu Exits Quantum, Closely Following Alibaba’s Earlier Move

January 5, 2024

Reuters reported this week that Baidu, China’s giant e-commerce and services provider, is exiting the quantum computing development arena. Reuters reported � Read more…

Comparing NVIDIA A100 and NVIDIA L40S: Which GPU is Ideal for AI and Graphics-Intensive Workloads?

October 30, 2023

With long lead times for the NVIDIA H100 and A100 GPUs, many organizations are looking at the new NVIDIA L40S GPU, which it’s a new GPU optimized for AI and g Read more…

Shutterstock 1179408610

Google Addresses the Mysteries of Its Hypercomputer 

December 28, 2023

When Google launched its Hypercomputer earlier this month (December 2023), the first reaction was, "Say what?" It turns out that the Hypercomputer is Google's t Read more…

AMD MI3000A

How AMD May Get Across the CUDA Moat

October 5, 2023

When discussing GenAI, the term "GPU" almost always enters the conversation and the topic often moves toward performance and access. Interestingly, the word "GPU" is assumed to mean "Nvidia" products. (As an aside, the popular Nvidia hardware used in GenAI are not technically... Read more…

Leading Solution Providers

Contributors

Shutterstock 1606064203

Meta’s Zuckerberg Puts Its AI Future in the Hands of 600,000 GPUs

January 25, 2024

In under two minutes, Meta's CEO, Mark Zuckerberg, laid out the company's AI plans, which included a plan to build an artificial intelligence system with the eq Read more…

China Is All In on a RISC-V Future

January 8, 2024

The state of RISC-V in China was discussed in a recent report released by the Jamestown Foundation, a Washington, D.C.-based think tank. The report, entitled "E Read more…

Shutterstock 1285747942

AMD’s Horsepower-packed MI300X GPU Beats Nvidia’s Upcoming H200

December 7, 2023

AMD and Nvidia are locked in an AI performance battle – much like the gaming GPU performance clash the companies have waged for decades. AMD has claimed it Read more…

Nvidia’s New Blackwell GPU Can Train AI Models with Trillions of Parameters

March 18, 2024

Nvidia's latest and fastest GPU, codenamed Blackwell, is here and will underpin the company's AI plans this year. The chip offers performance improvements from Read more…

Eyes on the Quantum Prize – D-Wave Says its Time is Now

January 30, 2024

Early quantum computing pioneer D-Wave again asserted – that at least for D-Wave – the commercial quantum era has begun. Speaking at its first in-person Ana Read more…

GenAI Having Major Impact on Data Culture, Survey Says

February 21, 2024

While 2023 was the year of GenAI, the adoption rates for GenAI did not match expectations. Most organizations are continuing to invest in GenAI but are yet to Read more…

The GenAI Datacenter Squeeze Is Here

February 1, 2024

The immediate effect of the GenAI GPU Squeeze was to reduce availability, either direct purchase or cloud access, increase cost, and push demand through the roof. A secondary issue has been developing over the last several years. Even though your organization secured several racks... Read more…

Intel’s Xeon General Manager Talks about Server Chips 

January 2, 2024

Intel is talking data-center growth and is done digging graves for its dead enterprise products, including GPUs, storage, and networking products, which fell to Read more…

  • arrow
  • Click Here for More Headlines
  • arrow
HPCwire